Zobrazeno 1 - 10
of 11
pro vyhledávání: '"David Gregornik"'
Publikováno v:
Advances in Molecular Pathology. 5:119-129
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d0fb11ce8361bbdb373ea0bc4de3dd7
https://doi.org/10.1016/j.yamp.2022.05.004
https://doi.org/10.1016/j.yamp.2022.05.004
Autor:
Joel F. Farley, David D. Stenehjem, Susan M. Wolf, Josiah D Allen, Constantin F. Aliferis, Erin J McGonagle, Steven G. Johnson, Robert J. Straka, Jason Wachtl, Catherine A. McCarty, Christine Kroger, Pinar Karaca Mandic, Pamala A. Pawloski, Allyson Schlichte, Julie England, Susie E Long, Heather Zierhut, Pamala A. Jacobson, Wayne T. Nicholson, Eric T. Matey, Sisi Ma, Stephen W. Schondelmeyer, Tiana Luczak, Suzette J. Bielinski, Pawel Mroz, Jacob T. Brown, Jeffrey R. Bishop, Jyothsna Giri, David Gregornik, Stephen C. Waring, Natasha Petry, R. Stephanie Huang, Ann M. Moyer, Marilyn K. Speedie, Randall D. Seifert, Brian G Van Ness
Publikováno v:
Pharmacogenomics
Several healthcare organizations across Minnesota have developed formal pharmacogenomic (PGx) clinical programs to increase drug safety and effectiveness. Healthcare professional and student education is strong and there are multiple opportunities in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f7d1067e6ad4f9ca3d0dfae5b952a9f
https://doi.org/10.2217/pgs-2021-0058
https://doi.org/10.2217/pgs-2021-0058
Autor:
Teresa T Ho, Gillian Bell, Roseann S Gammal, David Gregornik, Dyson T Wake, Henry M Dunnenberger
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 79(19)
Purpose This article explores approaches to pharmacogenomic counseling for patients who have undergone multigene panel testing by describing the collective experience of 5 institutions. Summary Multigene panel pharmacogenomic testing has the potentia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8617efc1a843d69776a44919a675440
https://pubmed.ncbi.nlm.nih.gov/35876085
https://pubmed.ncbi.nlm.nih.gov/35876085
Publikováno v:
Current opinion in pediatrics. 33(6)
PURPOSE OF REVIEW Pharmacogenomic insights provide an opportunity to optimize medication dosing regimens and patient outcomes. However, the potential for interindividual genomic variability to guide medication dosing and toxicity monitoring is not ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9b072e15709a1e0023e2f90a2bfea33
https://pubmed.ncbi.nlm.nih.gov/34561358
https://pubmed.ncbi.nlm.nih.gov/34561358
Publikováno v:
Pharmacogenomics. 22(3)
The accessibility of pharmacogenomic (PGx) testing has grown substantially over the last decade and with it has arisen a demand for patients to be counseled on the use of these tests. While guidelines exist for the use of PGx results; objective deter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d67b828ea7efeb7de1954926f2f17d6
https://pubmed.ncbi.nlm.nih.gov/33461326
https://pubmed.ncbi.nlm.nih.gov/33461326
Autor:
Joshua Wolf, J. T. Fannin, William Greene, Jennifer L. Pauley, Sima Jeha, Joseph N. Sciasci, Allison W. Bragg, Patrick Campbell, Hope D. Swanson, Delia C. Carias, David Gregornik, Melissa Quinn, Kristine R. Crews, Gabriela Maron
Publikováno v:
Antimicrobial Agents and Chemotherapy. 62
Pneumocystis jirovecii pneumonia is a life-threatening opportunistic infection in children receiving immunosuppressive chemotherapy. Without prophylaxis, up to 25% of pediatric oncology patients receiving chemotherapy will develop Pneumocystis jirove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b8fc46bb22670f6e5266236fa27c295
https://doi.org/10.1128/aac.00173-18
https://doi.org/10.1128/aac.00173-18
With the initiatives by the National Institutes of Health and the US Food and Drug Administration, pharmacogenomics is transitioning from the laboratory to patient care. Nearly 200 drug products now contain pharmacogenomic information as part of thei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0bd74d7495b3f748670224245588a67
https://europepmc.org/articles/PMC6336182/
https://europepmc.org/articles/PMC6336182/
Autor:
Deborah A. Ward, David Gregornik, Alejandro R Molinelli, Vinay M. Daryani, Shane J Cross, Rachel C. Brennan, Clinton F. Stewart, Li Tang, Yilun Sun, Jennifer L. Pauley, Jessica K. Roberts, Vanessa E. Millisor
Monitoring renal function is critical in treating pediatric patients, especially when dosing nephrotoxic agents. We evaluated the validity of the bedside Schwartz and Brandt equations in pediatric oncology patients and developed new equations for est
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4aa2340daa4aa0011c55e2afa67de179
https://europepmc.org/articles/PMC5712286/
https://europepmc.org/articles/PMC5712286/
Publikováno v:
Cancer chemotherapy and pharmacology. 43(1)
Purpose: To assess the pharmacokinetics of paclitaxel for recurrent Wilms' tumor in an anephric pediatric patient receiving hemodialysis. Methods: Paclitaxel was administered at a dose of 250 mg/m2 and 350 mg/m2 by 24-h continuous intravenous (IV) in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4f97d0782b1c9b2e540bfbd55bcaafb
https://pubmed.ncbi.nlm.nih.gov/9923547
https://pubmed.ncbi.nlm.nih.gov/9923547
Autor:
Junting Zheng, Melissa Pozotrigo, Katherine L Evans, David Gregornik, Stephen Harnicar, Nelly G. Adel, Sean M. Devlin, Nancy A. Kernan, Sherry Mathew, Juliet N. Barker, Andromachi Scaradavou, Doris M. Ponce
Publikováno v:
Blood. 122:3297-3297
Background Mycophenolate mofetil (MMF) is frequently combined with cyclosporine-A (CSA) as immunosuppression in unrelated donor CBT. Recent evidence suggests that therapeutic drug monitoring of mycophenolic acid (MPA), the active metabolite of MMF, i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8950ebb1ad74b87b38ca14cb5855184b
https://doi.org/10.1182/blood.v122.21.3297.3297
https://doi.org/10.1182/blood.v122.21.3297.3297